HOME
About
PORTFOLIO
More
AttackMS is a clinical trial measuring the effectiveness of treating
newly-diagnosed Multiple Sclerosis
with a stronger drug to delay MS progression
MS research shows that earlier treatment with an MS disease-modifying treatment can slow progression.
3 London recruitment hospitals